Furthermore, baseline CyTOF data revealed that patients in the Dara-refractory cluster had higher numbers of the senescent-type CD57+ T cells, which are known to be unable to inhibit growth of malignant cells and may have negatively affected the immune response to tumor antigens (29, 30). The gene discussed is B3GAT1; the disease is neoplasm.